INNATE PHARMA

Company Listings from SPi: INNATE PHARMA

You are here: Home >> SPi Company Listings >> INNATE PHARMA

 

INNATE PHARMA

Website:
http://

Search for other references to "innate" on SPi News

Latest INNATE PHARMA News

Innate Pharma reports first half 2019 financial results and business update Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH), today reports its consolidated financial results for the first six months of 2019. The financial statem...... 06:00 GMT Friday 13th September 2019

Number of shares and voting rights of Innate Pharma as at July 17, 2019 Pursuant to the article L. 233-8 II of the French « Code de Commerce » and the article 223-16 of the French stock-market authorities (, or “AMF”) charter, Innate Pharma SA...... 06:00 GMT Thursday 25th July 2019

Innate Pharma announces publication of IPH4102 Phase I clinical trial results for CTCL in the Lancet Oncology         ·        ·Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announced the online publication in of the results from the c...... 06:00 GMT Wednesday 26th June 2019

Innate Pharma to host key opinion leader call on IPH4102 “TELLOMAK” clinical trial design and rationale Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH), today announced that it will host a key opinion leader (KOL) call focused on the topic of IPH4102 “TE...... 06:00 GMT Thursday 20th June 2019

Innate Pharma announces intention to conduct a registered offering in the United States Innate Pharma, S.A. (Euronext Paris: IPH) today announced that it plans to conduct a registered public offering of its ordinary shares, in the form of American Depositary Shares (?...... 16:45 GMT Wednesday 12th June 2019

Innate Pharma to present IPH4102 “TELLOMAK” clinical trial design and preclinical PTCL data at the 2019 ICML Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announced that the design of the “TELLOMAK” Phase II trial and new preclinical data supporting...... 09:00 GMT Wednesday 12th June 2019

Innate Pharma enrolls first patient in IPH4102 TELLOMAK Phase II study Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announced that it has enrolled the first patient in the TELLOMAK Phase II study of IPH4102 in pati...... 06:00 GMT Thursday 6th June 2019

Innate Pharma announces publication in Cell on innovative multifunctional NKp46 NK cell engagers (NKCEs) Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announces the publication of data demonstrating the potential of multifunctional NKp46 NKCEs in ca...... 06:00 GMT Friday 31st May 2019

INNATE PHARMA ANNOUNCES PUBLICATION ON NEXT GENERATION IMMUNOTHERAPIES TARGETING THE ADENOSINE PATHWAY IN “CELL REPORTS” Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announced a publication in describing two new monoclonal antibodies, IPH5201 and IPH5301, that ta...... 06:00 GMT Thursday 23rd May 2019

Outcome of Annual General Meeting of May 22, 2019 Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces the results of the voting by shareholders at the Annual General Meeting (“AGM”) which took place on May 22, 2019,...... 06:00 GMT Thursday 23rd May 2019

Buy INNATE PHARMA
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us